InvestorsHub Logo
Followers 194
Posts 16621
Boards Moderated 10
Alias Born 01/29/2018

Re: Microlytics post# 6214

Monday, 11/29/2021 7:00:45 PM

Monday, November 29, 2021 7:00:45 PM

Post# of 7844
Selective reporting is a no-no. The value of all assets owned, including IP, must be shown on the balance sheet. I understand it may be an "undeveloped" asset, as patents are pretty worthless unless they can be commercialized/monetized, but they wouldn't have a zero value. All development costs have to appear on the cash flow sheets, as well. It is widespread on the OTC to sing about patents!!! and ignore the very fact there's a lot of things patented that are worthless because they can't be used to make money.

In the absence of an asset value on the balance sheet, there is zero value in the patents. In the absence of developmental costs on the cashflow sheet (ie - R & D), there is no ongoing development. They don't have any cash to do it anyway, whatever these patents that are "under the umbrella" are.

You cannot "decide when all my IP moves under the public entity," if the corporation owns it, it's supposed to be there.

And... if he's holding stuff like that back, he's also leaving the shareholders in the dark, and when you see that on the OTC, it's usually on purpose.

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.